BIOAVAILABILITY OF PIPEMIDIC ACID (PIPRAM) - 800-MG ONCE DAILY VERSUS 400-MG TWICE DAILY IN HUMAN VOLUNTEERS

被引：0
|
作者：
GUELEN, PJM
BOEREMA, JBJ
VREE, TB
机构：
来源：
TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH | 1987年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
下载
收藏
页码：71 / 75
页数：5
相关论文
共 50 条
  • [41] Treatment of community-acquired pneumonia by levofloxacin: 500 mg once daily or 500 mg twice daily?
    Zuck, P
    Bru, JP
    PRESSE MEDICALE, 2000, 29 (19): : 1062 - 1065
  • [42] LORATADINE (SCH29851) 40 MG ONCE DAILY VERSUS TERFENADINE 60 MG TWICE DAILY IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS
    BRUTTMANN, G
    PEDRALI, P
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1987, 15 (02) : 63 - 70
  • [43] Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)
    Takeuchi, Toshihisa
    Furuta, Takahisa
    Fujiwara, Yasuhiro
    Sugimoto, Mitsushige
    Kasugai, Kunio
    Kusano, Motoyasu
    Okada, Hiroyuki
    Suzuki, Takahiro
    Higuchi, Tomohiro
    Kagami, Takuma
    Uotani, Takahiro
    Yamade, Mihoko
    Sawada, Akinari
    Tanaka, Fumio
    Harada, Satoshi
    Ota, Kazuhiro
    Kojima, Yuichi
    Murata, Masaki
    Tamura, Yasuhiro
    Funaki, Yasushi
    Kawamura, Osamu
    Okamoto, Yuki
    Fujimoto, Kazuma
    Higuchi, Kazuhide
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (05) : 534 - 543
  • [44] Duloxetine at doses of 60 mg once daily and 60 mg twice daily is effective in treatment of diabetic neuropathic pain
    Iyengar, S
    Lu, YL
    D'Souza, DN
    Waninger, A
    Tran, P
    Wernicke, JF
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S147 - S147
  • [45] Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections
    Naber, KG
    Allin, DM
    Clarysse, L
    Haworth, DA
    James, IGV
    Raini, C
    Schneider, H
    Wall, A
    Weitz, P
    Hopkins, G
    Ankel-Fuchs, D
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (06) : 596 - 605
  • [46] CLINICAL-EVALUATION OF ROXITHROMYCIN 300 MG ONCE-DAILY - AN ALTERNATIVE TO 150 MG TWICE-DAILY
    PECHERE, JC
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 619 - 619
  • [47] FRONTLINE TREATMENT OF PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKEMIA WITH SEQUENTIAL ADMINISTRATION OF NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY: A PHASE 2 MULTICENTRIC STUDY
    Castagnetti, F.
    Rosti, G.
    Breccia, M.
    Stagno, F.
    Gozzini, A.
    Specchia, G.
    Capucci, A.
    Martino, B.
    Cambrin, G. Rege
    Luciano, L.
    Abruzzese, E.
    Bocchia, M.
    Cavazzini, F.
    Tiribelli, M.
    Pierri, I.
    Gugliotta, G.
    Palandri, F.
    Durante, S.
    Soverini, S.
    Testoni, N.
    Pane, F.
    Saglio, G.
    Alimena, G.
    Martinelli, G.
    Baccarani, M.
    HAEMATOLOGICA, 2012, 97 : 238 - 238
  • [48] Raltegravir: is a 400 mg once-daily dose enough?
    Lanzafame, Massimiliano
    Hill, Andrew
    Lattuada, Emanuela
    Calcagno, Andrea
    Bonora, Stefano
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (03) : 595 - 597
  • [49] Clinical acceptability of trimetazidine 80 mg once daily versus trimetazidine modified release 35 mg twice daily in chronic stable angina pectoris
    Pozdnyakov, Y.
    EUROPEAN HEART JOURNAL, 2016, 37 : 388 - 388
  • [50] Efficacy, safety and pharmacokinetics of atazanavir (200 mg twice daily) plus raltegravir (400 mg twice daily) dual regimen in the clinical setting
    Marinaro, Letizia
    Calcagno, Andrea
    Ripamonti, Diego
    Cenderello, Giovanni
    Pirriatore, Veronica
    Trentini, Laura
    Salassa, Bernardino
    Bramato, Caterina
    Orofino, Giancarlo
    D'Avolio, Antonio
    Rizzi, Marco
    Di Perri, Giovanni
    Rusconi, Stefano
    Bonora, Stefano
    JOURNAL OF CLINICAL VIROLOGY, 2017, 87 : 30 - 36
12345